You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunomodulatory Agents

Showing 26 - 50 of 6,024
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma Trial in Worldwide (LGX818, MEK162, Nivolumab)

Active, not recruiting
  • Metastatic Melanoma
  • Salzburg, AT, Austria
  • +29 more
Feb 23, 2022

Biology of the Injured Lung - Version 1

Completed
  • Respiratory Diseases
    • (no location specified)
    Jul 27, 2023

    Melanoma, Prostate Cancer, Renal Cancer Trial in Providence (Naltrexone)

    Terminated
    Has Results
    • Melanoma
    • +2 more
    • Providence, Rhode Island
      Miriam Hospital
    Feb 23, 2022

    Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in

    Completed
    • Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
    • PDR001
    • +5 more
    • Santa Monica, California
    • +24 more
    Mar 11, 2022

    Multiple Sclerosis Trial in Rouen (biological collection)

    Unknown status
    • Multiple Sclerosis
    • biological collection
    • Rouen, France
      Rouen University Hospital
    Mar 25, 2021

    Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Trial in Worldwide (PDR001, ACZ885, CJM112)

    Completed
    • Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
    • PDR001
    • +4 more
    • Baltimore, Maryland
    • +22 more
    Mar 15, 2022

    Multiple Myeloma Trial run by the National Cancer Institute (NCI) (Dexamethasone, Carfilzomib, Daratumumab)

    Recruiting
    • Multiple Myeloma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Oral Ulcer Trial in Tanta (use of basil extract gel in treatment of aphthus ulcer, muco adhesive gel, no treatment)

    Recruiting
    • Oral Ulcer
    • use of basil extract gel in treatment of aphthus ulcer
    • +2 more
    • Tanta, Egypt
      Malak Yousef Mohamed Shoukheba
    Jul 8, 2021

    Severe Acute Respiratory Syndrome Coronavirus 2, Severe Acute Respiratory Distress Syndrome Trial in Paris (Umbilical cord

    Completed
    • Severe Acute Respiratory Syndrome Coronavirus 2
    • Severe Acute Respiratory Distress Syndrome
    • Umbilical cord Wharton's jelly-derived human
    • NaCl 0.9%
    • Paris, France
    • +1 more
    Feb 17, 2022

    Minocycline, Cystoid Macular Edema Trial in Guangzhou (minocycline)

    Recruiting
    • Minocycline
    • Cystoid Macular Edema
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Jul 23, 2022

    Nodular Lymphocyte Predominant Hodgkin Lymphoma, Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma, Refractory Nodular

    Not yet recruiting
    • Nodular Lymphocyte Predominant Hodgkin Lymphoma
    • +2 more
    • Biopsy
    • +9 more
    • (no location specified)
    Jun 1, 2023

    Breast Cancer Trial in Bani Suwayf, Fayoum (Atorvastatin 80mg, )

    Recruiting
    • Breast Cancer
    • Atorvastatin 80mg
    • placebo
    • Banī Suwayf, Egypt
    • +1 more
    Oct 31, 2022

    Alopecia Areata Trial in Assiut (Betamethasone Valerate 0.1% Cream, Pentoxifylline, Metformin)

    Not yet recruiting
    • Alopecia Areata
    • Betamethasone Valerate 0.1% Cream
    • +2 more
    • Assiut, Egypt
      Assiut university
    Oct 15, 2023

    Osteo Arthritis Knee Trial in Abu Dhabi (Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))

    Recruiting
    • Osteo Arthritis Knee
    • Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
    • Abu Dhabi, United Arab Emirates
      Burjeel Medical City
    Oct 11, 2023

    Viremia, Bacteremia, Acute Rejection of Renal Transplant Trial (IVIG)

    Not yet recruiting
    • Viremia
    • +2 more
    • (no location specified)
    Apr 3, 2023

    COVID-19 Pneumonia Trial in New Haven (Tofacitinib 10 mg, Placebo)

    Terminated
    • COVID-19 Pneumonia
    • Tofacitinib 10 mg
    • Placebo
    • New Haven, Connecticut
      Yale New Haven Health System
    Mar 16, 2022

    HIV Trial (Lenalidomide, Adenosylmethionine)

    Not yet recruiting
    • HIV Infections
    • (no location specified)
    Oct 26, 2022

    HIV, Human Immunodeficiency Virus Trial in Salt Lake City (Euphorbia kansui extract powder prepared as tea)

    Suspended
    • HIV
    • Human Immunodeficiency Virus
    • Euphorbia kansui extract powder prepared as tea
    • Salt Lake City, Utah
      University of Utah
    Mar 22, 2022

    COVID-19 Trial in Minneapolis (Shionogi Protease Inhibitor (S-217622), )

    Recruiting
    • COVID-19
    • Shionogi Protease Inhibitor (S-217622)
    • placebo
    • Minneapolis, Minnesota
      University of Minnesota
    Jan 12, 2023

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Rochester (procedure, drug, biological)

    Not yet recruiting
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Biopsy
    • +10 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jun 9, 2023

    NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Iowa City, Iowa
      University of Iowa
    Oct 10, 2023

    Gastric Cancer Metastatic to Liver Trial (Thalidomide Combined With Chemotherapy and Monotherapy)

    Not yet recruiting
    • Gastric Cancer Metastatic to Liver
    • Thalidomide Combined With Chemotherapy and Monotherapy
    • (no location specified)
    Jan 17, 2022

    Peripheral T Cell Lymphoma Trial in Ann Arbor, Columbus, Madison (Nivolumab, cabiralizumab)

    Active, not recruiting
    Has Results
    • Peripheral T Cell Lymphoma
    • Ann Arbor, Michigan
    • +2 more
    Aug 13, 2021

    COVID-19 Trial in Cambridge (EDP1815, Dapagliflozin, Ambrisentan)

    Recruiting
    • COVID-19
    • Cambridge, Cambridgeshire, United Kingdom
      Cambridge University Hospitals NHS Foundation Trust
    Jun 9, 2021

    Multiple Myeloma Trial in New Haven (Elotuzumab, Belantamab mafodotin)

    Recruiting
    • Multiple Myeloma
    • New Haven, Connecticut
      Yale New Haven Hospital
    Aug 15, 2022